FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Feraheme (ferumoxytol) to update the product labeling following AMAG Pharmaceuticals' submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• Feraheme (ferumoxytol)

Snippet

SUPPL AP for FERAHEME (FERUMOXYTOL)